Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Rifabutina para el tratamiento de la tuberculosis pulmonar

Información

DOI:
https://doi.org/10.1002/14651858.CD005159.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 17 octubre 2007see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Enfermedades infecciosas

Clasificada:
  1. Actualización no planificada

    Research area no longer active

    This research area is no longer active

    Evaluada: 25 May 2018

Copyright:
  1. Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Geraint R Davies

    Correspondencia a: School of Clinical Sciences, University of Liverpool, Liverpool, UK

    [email protected]

  • Stefania Cerri

    Divisione di Pneumologia, Policlinico di Modena, Universita di Modena e Reggio Emilia, Modena, Italy

  • Luca Richeldi

    Divisione di Pneumologia, Policlinico di Modena, Universita di Modena e Reggio Emilia, Modena, Italy

Contributions of authors

G Davies formulated the review concept, wrote the protocol, extracted data, carried out the analysis, wrote the first draft, and co‐authored the final draft of the review. S Cerri assisted with protocol development, extracted data, and co‐authored the final draft of the review. L Richeldi assisted with protocol development, arbitrated during data extraction, and co‐authored the final draft of the review.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • The Wellcome Trust, UK.

Declarations of interest

G Davies is a co‐applicant for research funding of a large randomized controlled trial evaluating the use of rifampicin and rifabutin in conjunction with antiretroviral therapy. None known for S Cerri and L Richeldi.

Acknowledgements

The editorial base for the Cochrane Infectious Diseases Group is funded by the UK Department for International Development (DFID) for the benefit of developing countries.

Version history

Published

Title

Stage

Authors

Version

2007 Oct 17

Rifabutin for treating pulmonary tuberculosis

Review

Geraint R Davies, Stefania Cerri, Luca Richeldi

https://doi.org/10.1002/14651858.CD005159.pub2

2005 Jan 24

Rifabutin for treating pulmonary tuberculosis

Protocol

Geraint R Davies, Stefania Cerri, Luca Richeldi

https://doi.org/10.1002/14651858.CD005159

Differences between protocol and review

2007, Issue 4 (first review version): We included three‐month sputum culture conversion results as a secondary outcome measure since it also appeared potentially informative.